Products

Primary tabs

Export products to Excel

Displaying 1 - 15 of 16
Alternative Name: AF-2364
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: TBD
Project Stage: Lead Optimization
Alternative Name: Pericoital LNG gel
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Gel
Project Stage: Phase I
Alternative Name: Levonorgestrel (LNG) Intracervical Device (ICD)
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Vaginal, Other
Project Stage: Phase I
Alternative Name: MENT Transdermal Gel
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase I
Alternative Name: MENT Acetate Implant
Development Status: Active Development
Target: Male
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Phase II
Alternative Name: MZCL Combination IVR
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Pre-clinical
Alternative Name: Nestorone (NES) + Estradiol (E2) Vaginal Ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Phase II
Alternative Name: One-year contraceptive vaginal ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Regulatory
Alternative Name: Nestorone + Testosterone Gel
Development Status: Active Development
Target: Male
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase II
Alternative Name: Nestorone (NES) Single Rod Implant
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Phase II
Alternative Name: Nestorone (NES) Metered Dose Transdermal System® (MDTS®)
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase I
Alternative Name: Nestorone (NES) + Estradiol (E2) Transdermal Gel
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase II
Alternative Name: Progesterone Vaginal Ring (PVR)
Development Status: Limited Market Approval
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Regulatory
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Marketed
Alternative Name: Ulipristal acetate (UPA) Intrauterine System (IUS)
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Pre-clinical
Export to Excel